Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity - Kosiborod, Mikhail N.; Abildstrøm, Steen Z.; Borlaug, Barry A.; Butler, Javed; Rasmussen, Søren; Davies, Melanie; Hovingh, G. Kees; Kitzman, Dalane W.; Lindegaard, Marie L.; Møller, Daniél V.; Shah, Sanjiv J.; Treppendahl, Marianne B.; et al. (The New England journal of medicine, 2023)
Keywords: Antidiabetics; Body weight loss; C-reactive protein; Cardiology; Cardiomyopathy; Clinical Medicine; Clinical Medicine General; Congestive heart failure; Diabetes; Diet; Ejection fraction; Endocrinology; Gastroenterology; Gastrointestinal surgery; Glucagon-Like Peptides - adverse effects; Glucagon-Like Peptides - therapeutic use; Heart Failure; Heart Failure - complications; Heart Failure - drug therapy; Heart Failure - physiopathology; Humans; Intravenous therapy; Nutrition; Obesity; Obesity - complications; Overweight; Patients; Peptides; Placebos; Quality of life; Statistical analysis; Stroke Volume; Weight control